Detalhe da pesquisa
1.
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants.
Nature
; 596(7871): 273-275, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34111888
2.
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.
Nature
; 595(7868): 572-577, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34044428
3.
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
N Engl J Med
; 388(3): 214-227, 2023 01 19.
Artigo
Inglês
| MEDLINE | ID: mdl-36652353
4.
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
N Engl J Med
; 388(16): 1465-1477, 2023 Apr 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37018468
5.
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus.
N Engl J Med
; 389(3): 215-227, 2023 Jul 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37467497
6.
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
N Engl J Med
; 388(7): 621-634, 2023 02 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36791162
7.
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.
N Engl J Med
; 388(16): 1451-1464, 2023 Apr 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37018474
8.
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Nature
; 586(7830): 589-593, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32785213
9.
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Nature
; 586(7830): 594-599, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32998157
10.
Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy.
N Engl J Med
; 386(17): 1615-1626, 2022 04 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35476650
11.
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study.
N Engl J Med
; 386(25): 2377-2386, 2022 06 23.
Artigo
Inglês
| MEDLINE | ID: mdl-35731653
12.
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
N Engl J Med
; 386(1): 35-46, 2022 01 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34752019
13.
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
N Engl J Med
; 386(20): 1910-1921, 2022 05 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35320659
14.
A Phase 2 Extension Study Evaluating the Immunogenicity, Safety, and Tolerability of 3 or 4 Doses of a Clostridioides difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
J Infect Dis
; 229(2): 367-375, 2024 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37531657
15.
Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and Revaccination.
J Infect Dis
; 2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38606958
16.
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
N Engl J Med
; 385(3): 239-250, 2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34043894
17.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
N Engl J Med
; 385(19): 1761-1773, 2021 11 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34525277
18.
Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial.
Clin Infect Dis
; 77(2): 312-320, 2023 07 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37125490
19.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med
; 383(27): 2603-2615, 2020 12 31.
Artigo
Inglês
| MEDLINE | ID: mdl-33301246
20.
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
N Engl J Med
; 383(25): 2439-2450, 2020 12 17.
Artigo
Inglês
| MEDLINE | ID: mdl-33053279